--- a +++ b/matching/trials/NCT01253486.xml @@ -0,0 +1,207 @@ +<?xml version="1.0" encoding="UTF-8"?> +<clinical_study rank="105722"> + <!-- This xml conforms to an XML Schema at: + https://clinicaltrials.gov/ct2/html/images/info/public.xsd + and an XML DTD at: + https://clinicaltrials.gov/ct2/html/images/info/public.dtd --> + <required_header> + <download_date>ClinicalTrials.gov processed this data on December 16, 2015</download_date> + <link_text>Link to the current ClinicalTrials.gov record.</link_text> + <url>https://clinicaltrials.gov/show/NCT01253486</url> + </required_header> + <id_info> + <org_study_id>GMM 2010</org_study_id> + <nct_id>NCT01253486</nct_id> + </id_info> + <brief_title>Expressive Writing for Heart Healing</brief_title> + <acronym>WrittenHeart</acronym> + <official_title>Use of Expressive Writing in the Cardiac Rehabilitation of Obese In-patients With Ischemic Heart Disease (IHD)</official_title> + <sponsors> + <lead_sponsor> + <agency>Istituto Auxologico Italiano</agency> + <agency_class>Other</agency_class> + </lead_sponsor> + </sponsors> + <source>Istituto Auxologico Italiano</source> + <oversight_info> + <authority>Italy: Ethics Committee</authority> + <has_dmc>No</has_dmc> + </oversight_info> + <brief_summary> + <textblock> + This study will determine whether the psychological and physical benefits of expressive + writing extend to obese in-patients with Ischemic Heart Disease (IHD)referred to cardiac + rehabilitation + </textblock> + </brief_summary> + <detailed_description> + <textblock> + Expressive writing, for as little as 3-5 sessions of 20 minutes, has been found to improve + both physical and psychological health based on health outcome measures such as number of + doctor's visits and hospital days, blood pressure control, lung and immune function, pain, + anxiety and depression. Given its simplicity and obvious advantages in terms of + cost-effectiveness, expressive writing has great potential as a therapeutic tool or as a + means of self-help, either alone or as an adjunct to traditional therapies. This modality + has not been studied in obese patients with Ischemic Heart Disease. + </textblock> + </detailed_description> + <overall_status>Completed</overall_status> + <start_date>January 2010</start_date> + <completion_date type="Actual">May 2013</completion_date> + <primary_completion_date type="Actual">September 2012</primary_completion_date> + <phase>N/A</phase> + <study_type>Interventional</study_type> + <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design> + <primary_outcome> + <measure>SF12</measure> + <time_frame>1 year</time_frame> + <safety_issue>No</safety_issue> + <description>The SF12 is a generic measure of both physical and emotional components of health-related quality of life</description> + </primary_outcome> + <primary_outcome> + <measure>BDI-II</measure> + <time_frame>1 year</time_frame> + <safety_issue>No</safety_issue> + <description>The Beck Depression Inventory is a measure of depressive symptoms</description> + </primary_outcome> + <primary_outcome> + <measure>BDI</measure> + <time_frame>1 year</time_frame> + <safety_issue>No</safety_issue> + <description>The Beck Anxiety Inventory is a measure of cognitive and somatic symptoms of anxiety</description> + </primary_outcome> + <primary_outcome> + <measure>Brief-PTGI</measure> + <time_frame>1 year</time_frame> + <safety_issue>No</safety_issue> + <description>The Brief Post-Traumatic Growth Inventory is a measure of positive growth following adversity</description> + </primary_outcome> + <secondary_outcome> + <measure>BMI</measure> + <time_frame>1 year</time_frame> + <safety_issue>No</safety_issue> + <description>Body Mass Index (BMI) is a measure of obesity and is calculated as weight in kilograms divided by height in meters squared</description> + </secondary_outcome> + <secondary_outcome> + <measure>Multiple Coronary Risk Factors</measure> + <time_frame>1 year</time_frame> + <safety_issue>No</safety_issue> + <description>Hypertension, HDL, LDL,</description> + </secondary_outcome> + <secondary_outcome> + <measure>METs</measure> + <time_frame>1 year</time_frame> + <safety_issue>No</safety_issue> + <description>Metabolic equivalents are a measure of exercise capacity. 1 MET represents the amount of oxygen consumed at rest and is equal to approximately 3.5 ml O2 kg-1 min-1</description> + </secondary_outcome> + <number_of_arms>4</number_of_arms> + <enrollment type="Actual">100</enrollment> + <condition>Ischemic Heart Disease</condition> + <condition>Obesity</condition> + <arm_group> + <arm_group_label>Disease-related expressive writing</arm_group_label> + <arm_group_type>Experimental</arm_group_type> + <description>Participants in the disease-related expressive writing condition write about their feelings about cardiac disease four times, for at least 20 minutes each time, during a two week period</description> + </arm_group> + <arm_group> + <arm_group_label>Traditional expressive writing</arm_group_label> + <arm_group_type>Active Comparator</arm_group_type> + <description>Participants in the traditional expressive writing condition write about their feelings about one or more stressful experiences they lived in the past, for at least 20 minutes each time, during a two week period</description> + </arm_group> + <arm_group> + <arm_group_label>Neutral writing</arm_group_label> + <arm_group_type>Sham Comparator</arm_group_type> + <description>Participants in the neutral writing condition write about the facts about cardiac disease, for at least 20 minutes each time, during a two week period</description> + </arm_group> + <arm_group> + <arm_group_label>Control condition</arm_group_label> + <arm_group_type>No Intervention</arm_group_type> + <description>Participants in the control condition do not receive any intervention and complete only the assessments</description> + </arm_group> + <intervention> + <intervention_type>Behavioral</intervention_type> + <intervention_name>Disease-related Expressive writing</intervention_name> + <description>Participants in the disease-related expressive writing condition write about their feelings about cardiac disease four times, for at least 20 minutes each time, during a two week period.</description> + <arm_group_label>Disease-related expressive writing</arm_group_label> + </intervention> + <intervention> + <intervention_type>Behavioral</intervention_type> + <intervention_name>Active Comparator: Traditional expressive writing</intervention_name> + <description>Participants in the traditional expressive writing condition write about their feelings about one or more stressful experiences they lived in the past, for at least 20 minutes each time, during a two week period</description> + <arm_group_label>Traditional expressive writing</arm_group_label> + </intervention> + <intervention> + <intervention_type>Behavioral</intervention_type> + <intervention_name>Sham Comparator: Neutral writing</intervention_name> + <description>Participants in the neutral writing condition write about the facts about cardiac disease, for at least 20 minutes each time, during a two week period</description> + <arm_group_label>Neutral writing</arm_group_label> + </intervention> + <eligibility> + <criteria> + <textblock> + Inclusion Criteria: + + - obesity + + - Ischemic Heart disease + + - Signed informed consent + + Exclusion Criteria: + + - Visual or manual limitations that preclude reading and writing + + - Unwilling to participate + </textblock> + </criteria> + <gender>Both</gender> + <minimum_age>N/A</minimum_age> + <maximum_age>70 Years</maximum_age> + <healthy_volunteers>No</healthy_volunteers> + </eligibility> + <overall_official> + <last_name>Gianluca Castelnuovo, Ph.D.</last_name> + <role>Principal Investigator</role> + <affiliation>Istituto Auxologico Italiano</affiliation> + </overall_official> + <location> + <facility> + <name>San Giuseppe Hospital, Istituto Auxologico Italiano IRCSS</name> + <address> + <city>Verbania</city> + <zip>28921</zip> + <country>Italy</country> + </address> + </facility> + </location> + <location_countries> + <country>Italy</country> + </location_countries> + <link> + <url>http://www.auxologico.it</url> + </link> + <reference> + <citation>Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychol Bull. 2006 Nov;132(6):823-65.</citation> + <PMID>17073523</PMID> + </reference> + <verification_date>September 2013</verification_date> + <lastchanged_date>September 23, 2013</lastchanged_date> + <firstreceived_date>December 2, 2010</firstreceived_date> + <responsible_party> + <responsible_party_type>Principal Investigator</responsible_party_type> + <investigator_affiliation>Istituto Auxologico Italiano</investigator_affiliation> + <investigator_full_name>Gianluca Castelnuovo</investigator_full_name> + <investigator_title>Professor</investigator_title> + </responsible_party> + <keyword>expressive writing</keyword> + <keyword>cardiac rehabilitation</keyword> + <is_fda_regulated>No</is_fda_regulated> + <has_expanded_access>No</has_expanded_access> + <condition_browse> + <!-- CAUTION: The following MeSH terms are assigned with an imperfect algorithm --> + <mesh_term>Coronary Artery Disease</mesh_term> + <mesh_term>Heart Diseases</mesh_term> + <mesh_term>Myocardial Ischemia</mesh_term> + </condition_browse> + <!-- Results have not yet been posted for this study --> +</clinical_study>